Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:42 UTC |
---|
HMDB ID | HMDB0014669 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Lercanidipine |
---|
Description | Lercanidipine is only found in individuals that have used or taken this drug. It is a calcium channel blocker of the dihydropyridine class. It is sold under various commercial names including Zanidip.By deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum, Lercanidipine inhibits the influx of extracellular calcium across the myocardial and vascular smooth muscle cell membranes The decrease in intracellular calcium inhibits the contractile processes of the myocardial smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload. |
---|
Structure | COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1 InChI=1S/C36H41N3O6/c1-24-31(34(40)44-6)33(28-18-13-19-29(22-28)39(42)43)32(25(2)37-24)35(41)45-36(3,4)23-38(5)21-20-30(26-14-9-7-10-15-26)27-16-11-8-12-17-27/h7-19,22,30,33,37H,20-21,23H2,1-6H3 |
---|
Synonyms | Value | Source |
---|
Lercanil | Kegg | Zanidip | HMDB | Biohorm brand OF lercanidipine hydrochloride | HMDB | Lercadip | HMDB | Lerdip | HMDB | Lercanidipine hydrochloride | HMDB | Methyl-1,1-dimethyl-2-(N-(3,3-diphenylpropyl)-N-methylamino)ethyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | HMDB |
|
---|
Chemical Formula | C36H41N3O6 |
---|
Average Molecular Weight | 611.7272 |
---|
Monoisotopic Molecular Weight | 611.299536059 |
---|
IUPAC Name | 3-{1-[(3,3-diphenylpropyl)(methyl)amino]-2-methylpropan-2-yl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
---|
Traditional Name | lercanidipine |
---|
CAS Registry Number | 100427-26-7 |
---|
SMILES | COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C36H41N3O6/c1-24-31(34(40)44-6)33(28-18-13-19-29(22-28)39(42)43)32(25(2)37-24)35(41)45-36(3,4)23-38(5)21-20-30(26-14-9-7-10-15-26)27-16-11-8-12-17-27/h7-19,22,30,33,37H,20-21,23H2,1-6H3 |
---|
InChI Key | ZDXUKAKRHYTAKV-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as quinazolines. Quinazolines are compounds containing a quinazoline moiety, which is made up of two fused six-member aromatic rings, a benzene ring and a pyrimidine ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazanaphthalenes |
---|
Sub Class | Benzodiazines |
---|
Direct Parent | Quinazolines |
---|
Alternative Parents | |
---|
Substituents | - Quinazoline
- Secondary aliphatic/aromatic amine
- Toluene
- Aryl chloride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Organosulfonic acid amide
- Organic sulfonic acid or derivatives
- Vinylogous amide
- Aminosulfonyl compound
- Tertiary carboxylic acid amide
- Sulfonyl
- Organosulfonic acid or derivatives
- Amino acid or derivatives
- Carboxamide group
- Lactam
- Carboxylic acid derivative
- Secondary amine
- Azacycle
- Organic oxide
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Amine
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.00016 g/L | Not Available | LogP | 6.4 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross SectionsAdduct Type | Data Source | CCS Value (Å2) | Reference |
---|
[M+H]+ | CBM | 249.8 | 30932474 |
|
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Lercanidipine,1TMS,isomer #1 | COC(=O)C1=C(C)N([Si](C)(C)C)C(C)=C(C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C2=CC=CC=C2)C1C1=CC=CC([N+](=O)[O-])=C1 | 4076.3 | Semi standard non polar | 33892256 | Lercanidipine,1TMS,isomer #1 | COC(=O)C1=C(C)N([Si](C)(C)C)C(C)=C(C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C2=CC=CC=C2)C1C1=CC=CC([N+](=O)[O-])=C1 | 3087.9 | Standard non polar | 33892256 | Lercanidipine,1TMS,isomer #1 | COC(=O)C1=C(C)N([Si](C)(C)C)C(C)=C(C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C2=CC=CC=C2)C1C1=CC=CC([N+](=O)[O-])=C1 | 5485.5 | Standard polar | 33892256 | Lercanidipine,1TBDMS,isomer #1 | COC(=O)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C)=C(C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C2=CC=CC=C2)C1C1=CC=CC([N+](=O)[O-])=C1 | 4339.1 | Semi standard non polar | 33892256 | Lercanidipine,1TBDMS,isomer #1 | COC(=O)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C)=C(C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C2=CC=CC=C2)C1C1=CC=CC([N+](=O)[O-])=C1 | 3362.0 | Standard non polar | 33892256 | Lercanidipine,1TBDMS,isomer #1 | COC(=O)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C)=C(C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C2=CC=CC=C2)C1C1=CC=CC([N+](=O)[O-])=C1 | 5415.2 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Lercanidipine GC-MS (Non-derivatized) - 70eV, Positive | splash10-000i-2191010000-9a91ea6a126944a1a4fb | 2017-09-01 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lercanidipine 10V, Positive-QTOF | splash10-03di-0000009000-9d9d3cd84299b9a1b718 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lercanidipine 20V, Positive-QTOF | splash10-00di-0000019000-b7c19cb600de37512b6b | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lercanidipine 40V, Positive-QTOF | splash10-0006-5094013000-61550404c96e9879a052 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lercanidipine 10V, Negative-QTOF | splash10-03di-0000009000-c5578a9d7353dd125399 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lercanidipine 20V, Negative-QTOF | splash10-03di-0000009000-93862893f933ac09e4de | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lercanidipine 40V, Negative-QTOF | splash10-006x-4092013000-f3bb297f4ce55e9fbe12 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lercanidipine 10V, Negative-QTOF | splash10-03di-0000119000-0687db4621b20c64d0bc | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lercanidipine 20V, Negative-QTOF | splash10-0329-5897346000-a2e4782ffaec352368fc | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lercanidipine 40V, Negative-QTOF | splash10-0002-9500010000-35785b7411b57538ca96 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lercanidipine 10V, Positive-QTOF | splash10-01q9-0937146000-3dbff6a5bec63ea95406 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lercanidipine 20V, Positive-QTOF | splash10-000t-0942011000-5b5db8b5b9de4bd20d10 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lercanidipine 40V, Positive-QTOF | splash10-014i-1920000000-573f0fda3422bc5dde78 | 2021-09-23 | Wishart Lab | View Spectrum |
|
---|
General References | - Agrawal R, Marx A, Haller H: Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension. J Hypertens. 2006 Jan;24(1):185-92. [PubMed:16331117 ]
- Martinez ML, Lopes LF, Coelho EB, Nobre F, Rocha JB, Gerlach RF, Tanus-Santos JE: Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension. J Cardiovasc Pharmacol. 2006 Jan;47(1):117-22. [PubMed:16424795 ]
- Lin TH, Voon WC, Yen HW, Huang CH, Su HM, Lai WT, Sheu SH: Lercanidipine and losartan effects on blood pressure and fibrinolytic parameters. Kaohsiung J Med Sci. 2006 Apr;22(4):177-83. [PubMed:16679299 ]
|
---|